 |
|
 |
| Research, Select, & Monitor |
Monday, April 23, 2018 11:35:47 AM ET |
|
|
|
|
|
|
| Balance Sheet for Karyopharm Therapeutics Inc |
| (Amounts are in millions) |
| 12/2017 |
| 12/2016 |
| 12/2015 |
| Cash |
| $69.20 |
| $49.66 |
| $58.36 |
| Marketable Securities |
| $77.47 |
| $79.89 |
| $117.28 |
| Receivables |
| $0.00 |
| $0.00 |
| $0.00 |
| Inventory |
| $0.00 |
| $0.00 |
| $0.00 |
| Raw Materials |
| N/A |
| N/A |
| N/A |
| Work in Progress |
| N/A |
| N/A |
| N/A |
| Finished Goods |
| N/A |
| N/A |
| N/A |
| Notes Receivable |
| $0.00 |
| $0.00 |
| $0.00 |
| Other Current Assets |
| $1.75 |
| $2.08 |
| $1.97 |
|
|
 |
|
|
|
|
| Total Current Assets |
| $148.42 |
| $131.64 |
| $177.60 |
| |
|
|
|
|
|
|
| Property, Plant & Equipment |
| $4.74 |
| $4.68 |
| $4.61 |
| Accumulated Depreciation |
| $2.56 |
| $1.85 |
| $1.13 |
| Net Property, Plant & Equipment |
| $2.19 |
| $2.84 |
| $3.48 |
| Investment & Advances |
| $29.40 |
| $45.43 |
| $33.88 |
| Other non-current Assets |
| $0.00 |
| $0.00 |
| $0.00 |
| Deferred Charges |
| $0.00 |
| $0.00 |
| $0.00 |
| Intangibles |
| $0.00 |
| $0.00 |
| $0.00 |
| Deposits & other assets |
| $0.29 |
| $0.48 |
| $0.48 |
|
|
|
|
|
|
|
| TOTAL ASSETS |
| $180.29 |
| $180.39 |
| $215.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| Notes Payable |
| $0.00 |
| $0.00 |
| $0.00 |
| Accounts Payable |
| $5.67 |
| $4.75 |
| $3.81 |
| Current Portion of Long-term Debt |
| $0.00 |
| $0.00 |
| $0.00 |
| Current Portion of Capital Leases |
| $0.00 |
| $0.00 |
| $0.00 |
| Accrued Expenses |
| $21.45 |
| $11.36 |
| $11.02 |
| Income Taxes Payable |
| $0.00 |
| $0.00 |
| $0.00 |
| Other Current Liabilities |
| $22.36 |
| $0.36 |
| $0.30 |
|
|
|
|
|
|
|
| Total Current Liabilities |
| $49.47 |
| $16.48 |
| $15.13 |
| |
|
|
|
|
|
|
| Mortgages |
| $0.00 |
| $0.00 |
| $0.00 |
| Deferred Charges (taxes/income) |
| $1.36 |
| $1.67 |
| $1.95 |
| Convertible Debt |
| $0.00 |
| $0.00 |
| $0.00 |
| Long Term Debt |
| $0.00 |
| $0.00 |
| $0.00 |
| Non-Current Capital Leases |
| $0.00 |
| $0.00 |
| $0.00 |
| Other Long-Term Debt |
| $0.00 |
| $0.00 |
| $0.00 |
| Minority Interest (liabilities) |
| $0.00 |
| $0.00 |
| $0.00 |
|
|
|
|
|
|
|
| TOTAL LIABILITIES |
| $50.83 |
| $18.14 |
| $17.08 |
| |
|
|
|
|
|
|
| Preferred Stock |
| $0.00 |
| $0.00 |
| $0.00 |
| Common Stock, Net |
| $0.01 |
| $0.00 |
| $0.00 |
| Capital Surplus |
| $625.02 |
| $528.62 |
| $455.17 |
| Retained Earnings |
| ($495.34) |
| ($366.10) |
| ($256.53) |
| Treasury Stock |
| $0.00 |
| $0.00 |
| $0.00 |
| Other Liabilities |
| ($0.22) |
| ($0.27) |
| ($0.28) |
|
|
|
|
|
|
|
| SHAREHOLDERS' EQUITY |
| $129.46 |
| $162.24 |
| $198.37 |
|
|
|
|
|
|
|
| TOTAL LIABILITES &SHAREHOLDERS EQUITY |
| $180.29 |
| $180.39 |
| $215.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Past performance is not indicative of future results
StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.
|